A Pilot Study on the Impact of Two Different Doses of Ciclesonide (160 mcg/Day and 320 mcg/Day) Administered in the Evening on Quality of Life in Patients With Moderate Persistent Asthma

Trial Profile

A Pilot Study on the Impact of Two Different Doses of Ciclesonide (160 mcg/Day and 320 mcg/Day) Administered in the Evening on Quality of Life in Patients With Moderate Persistent Asthma

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Dec 2016

At a glance

  • Drugs Ciclesonide (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Jul 2008 Nycomed reported as trial affliate by ClinicalTrials.gov.
    • 01 Feb 2007 Status changed from recruiting.
    • 14 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top